This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial.
Mayo Clinic proceedings, 92(2), 200-210
Citation
Cosman, Felicia; Miller, Paul D; Williams, Gregory C; Hattersley, Gary; Hu, Ming-Yi; Valter, Ivo; Fitzpatrick, Lorraine A; Riis, Bente Juel; Christiansen, Claus; Bilezikian, John P; Black, Dennis. (2017). Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial.. Mayo Clinic proceedings, 92(2), 200-210. https://doi.org/10.1016/j.mayocp.2016.10.009